logo

59 pages 1 hour read

Outlive: The Science and Art of Longevity

Nonfiction | Book | Adult | Published in 2023

A modern alternative to SparkNotes and CliffsNotes, SuperSummary offers high-quality Study Guides with detailed chapter summaries and analysis of major themes, characters, and more.

Themes

The Importance of Living Better for Longer

Attia tells the story of the mythical Greek prince of Troy, Tithonus. He asked the gods for immortality. However, since he did not also ask for eternal youth, “his body continued to decay” (10). This story illustrates the two key concepts of longevity: chronological lifespan (which is what Tithonus asked for) and healthspan (which is what Tithonus failed to ask for). Attia’s primary argument is that we should not only want to live longer, but to live better for longer.

He notes that “to live to the age of one hundred without our mind and our body intact is not something that anyone would willingly choose” (46). Outlive is thus a call to action for the practice of longevity. Attia emphasizes that his “intent here is not to tell you exactly what to do; it’s to help you learn how to think about doing these things” (18).

He presents a three-part approach to longevity. The first part is an individual’s objective. The overall objective is to live longer with a good quality of life. Each person defines what “good quality” means to them. Strategy involves research and figuring out a way to achieve our individual objectives related to longevity. Attia suggests strategy is more difficult than tactics, and needs to extend both lifespan and healthspan. Attia focuses on strategies in Part 2. Here, he provides the biological mechanisms that predispose people to the Horsemen diseases as well as discussions about how these diseases progress. Doing so enables people “to know our adversary [Horsemen diseases] inside and out” (211), which helps them with the final approach to longevity.

The final part is tactics. Tactics are what people do to achieve longevity. He focuses on five tactical domains: exercise, nutrition, sleep, emotional health, and exogenous molecules. Attia considers exercise to be the most powerful longevity tool and encourages everyone to exercise (especially if they currently do not). One powerful statistic that Attia cites is that adding just 90 minutes of exercise each week reduces a person’s risk of dying from all Four Horsemen diseases by almost 15 percent. Habitual exercisers “tend to live longer, but they stay in better health, with less morbidity from causes related to metabolic dysfunction” (218). Attia breaks exercise down into its most important components for longevity: aerobic efficiency and endurance, strength, and stability. He argues for increasing limits in each component to achieve extended lifespan and healthspan and provides suggestions for how to do so.

Attia concludes that we know very little about nutrition itself. As a result, he vehemently disagrees with fad diets. Instead, Attia argues that people need to create their own meal plans based on tweaking the three major levers of diet (caloric restriction, dietary restriction, and time restriction) and the four main carbohydrates (alcohol, protein, fats, and carbohydrates).

Sleep is one of the most under-utilized tactical domains, yet decades of research have shown that sleep is critical to living longer and living better for longer. Good quantity and quality sleep ensures good metabolic, heart, and brain health. Lack of sleep has profound negative consequences including increasing the risks of the Horsemen diseases.

Emotional health is the most important component of healthspan. When someone is in emotional equilibrium, they are happy and have strong relationships with themselves and others. Using his own personal story, Attia underscores that poor emotional health likely shortens healthspan, since few people want to live longer if they are unhappy. In urging readers to consider all of these factors in their quest for better health and longevity, Attia urges readers to approach their health in a way that considers how to make their life a happy one, not just a long one.

The Failures of Mainstream Medicine (Medicine 2.0)

Attia argues that the primary failure of Medicine 2.0 is that it avoids “icebergs,” or the symptoms that something is going wrong in the human body. Medicine 2.0 only intervenes when the Horsemen diseases present themselves. By this stage, it is almost impossible to reverse them. Thus, people’s healthspan (and lifespan) drastically decreases. Attia thus wishes to both expose and address the failures of Medicine 2.0. to find a better way forward.

With regards to metabolic dysfunction, there are five criteria that suggest an individual is becoming metabolically sick: high blood pressure; high lipid in the blood (triglycerides); low HDL cholesterol; obesity; and elevated fasting glucose. When an individual has three or more of these traits, they have metabolic syndrome. A Medicine 2.0 approach would be to wait until someone has all three traits and then treat them accordingly, yet by this time, they are seriously metabolically unhealthy. As Attia documents in later chapters, metabolic health helps reduce the risk factors associated with the other Horsemen diseases. Thus, a person likely does not just have metabolic syndrome but one of the other slow-moving chronic diseases. By not addressing metabolic health, we are setting people up to face a number of serious health matters.

Medicine 2.0 also has three “blind spots” when it comes to heart disease. The first is that it fails to address the importance of total lipoprotein burden (apoB) over lipids. The second does not include Lp(a) in its tests associated with assessing cardiovascular risk. Finally, like the other Horsemen diseases, Medicine 2.0 does not grasp how long heart disease builds in the body. Medicine 2.0’s war against cancer is also not going well, despite decades of cancer research. Medical professionals still do not understand the genesis and progression of most cancers. Unfortunately, by the time doctors detect cancer, it has been progressing in a patient’s body for some time, making treatment difficult. Our ability to detect early stages of cancer also remains poor. Metabolic dysfunctions, including obesity, insulin resistance, and type 2 diabetes, also appear to be drivers of cancer. Finally, Attia notes that the “scariest aspect of Alzheimer’s disease boils down to this: Medicine 2.0 cannot help us at all” (204). By the time Medicine 2.0 intervenes, a person has already been diagnosed with dementia. As of right now, we do not have treatments that reverse this cognitive impairment.

To Attia, Medicine 2.0 fails for two primary reasons. The first is that “our ‘radar’ [ability to detect the Horsemen diseases] is not powerful enough” (35). As a result, we do not catch the early stages of the Horsemen diseases. These diseases are generally more difficult to treat in advanced stages. The second reason is Medicine 2.0’s mindset, particularly its aversion to risk. Attia blames this aversion on Hippocrates, who systematized the study of medicine, wrote a large body of medical literature, and supposedly created the famous Hippocratic Oath. Attia takes issue with the Hippocratic Oath, which is “‘First, do no harm’” (23). According to Attia, Hippocrates never uttered these words. More importantly, Attia finds the oath problematic because it implies “that the best treatment option is always the one with the least immediate downside risk—and, very often, doing nothing at all” (24). Attia strongly argues that risk is inherent in everything humans do. Therefore, the field of medicine cannot and should not avoid risk.

Proactive Versus Reactive Medicine

Throughout Outlive, Attia advocates for proactive rather than reactive medicine. He strongly prefers that the medical field shift from focusing on treatment and cures to prevention for the Horsemen diseases. The primary reason is that he believes we should be able to intervene before a person actually develops the disease. For each of the Horsemen diseases, Attia presents icebergs (or signs of danger associated with the disease) and tests or genetic screenings that people can do to monitor biomarkers.

The five markers of metabolic dysfunction is one example. Medicine 2.0 doctors will not intervene until a patient has several of the markers. Attia questions this approach: “Why wait until someone has three of the five markers? Any one of them is generally a bad sign” (108). Instead, he suggests that people monitor biomarkers related to metabolism, including elevated insulin, chronic inflammation, elevated ALT liver enzymes, and higher levels of uric acid. These biomarkers help people understand their metabolic health in real-time.

Attia also advocates for Lp(a) testing, which Medicine 2.0 still largely ignores. Lp(a) belongs to the apoB particle family, and it is even more likely than LDL to get stuck on the artery wall. It is especially dangerous because it helps speed-up the formation of arterial plaque. Attia notes that “often the way Lp(a) announces itself is via a sudden, seemingly premature heart attack” (128). It is also passed down hereditarily. Elevated Lp(a) is thus a warning sign that something is dangerously wrong in the body. Attia tells the story of one of his patients, Anahad, who fortunately discovered he had elevated Lp(a) levels before a catastrophic cardiac event occurred: “luckily, we found the trouble before the trouble found him” (130).

Attia also strongly recommends early and aggressive cancer screenings, especially for prostate and colon cancers—a perspective which is still very controversial in Medicine 2.0. Medicine 2.0 believes that the false positives and emotional and financial toll of cancer screenings outweigh the benefits of catching cancer early. Attia vehemently disagrees with this approach. He also believes that people should look at newer types of screenings, such as liquid biopsies that use a blood test to detect the presence of cancer.

Testing for the APOE e4 genotype is another example, particularly since carriers have a substantially higher risk for Alzheimer’s disease. Many doctors still feel that the test is pointless since Alzheimer’s disease remains irreversible. Thus, they feel people are better off not knowing whether they carry this genotype. This perspective is short-sighted, as attested by Stephanie’s story in Chapter 9. Medicine 2.0 doctors would not have tested Stephanie for the APOE e4 genotype because she was young and in seemingly good health. Attia tested her, however, and she was in fact a carrier. Initially, she took the news hard, but she and Attia put together a prevention plan which included changes to her diet and exercise that will help her strengthen and maintain metabolic, heart, and brain health, hopefully reducing her risks of developing dementia and Alzheimer's disease. Knowing our risks for the Horsemen diseases thus enables us to create a tailored longevity strategy with tactics that reduce these risks.

blurred text
blurred text
blurred text
blurred text
Unlock IconUnlock all 59 pages of this Study Guide

Plus, gain access to 8,800+ more expert-written Study Guides.

Including features:

+ Mobile App
+ Printable PDF
+ Literary AI Tools